Key result
Supervised physical exercise during breast cancer chemotherapy resulted in a non-significant LVEF reduction (to 61.0%, p=0.131), whereas controls had a significant reduction (to 60.6%, p=0.008).
Why the study?
Adjuvant breast cancer treatments are associated with side effects including reduced LVEF that can cause severe cardiac damage and progress to heart failure.
Does a supervised physical exercise program prevent the reduction of left ventricular ejection fraction in women with breast cancer undergoing chemotherapy?
Does a supervised physical exercise program prevent the reduction of left ventricular ejection fraction in women with breast cancer undergoing chemotherapy?
Absolute Event Rate: 61% vs 60.57%
A supervised physical exercise program during breast cancer chemotherapy may attenuate the decline in left ventricular ejection fraction, suggesting a potential cardioprotective effect.
Highlights cardiac monitoring needs during BC adjuvant therapy; hypothesis-generating and requires validation in larger cohorts.
Breast cancer (BC) is the most common cancer among women, with an incidence of 85–94 per 100,000 people annually in Europe. Despite the increasing incidence of BC, advancements in early detection and novel therapeutic approaches have improved survival rates. However, adjuvant treatments are associated with side effects, including a reduction in the left ventricular ejection fraction (LVEF), which can result in severe cardiac damage and progress to heart failure. Methods: Thirty-eight women undergoing BC treatment were included in the study. Eighteen women (47.2 ± 5.4 years old) participated in a supervised physical exercise (PE) program for 60 min/day, twice weekly, at moderate to high intensity (5 min joint mobilization, 20 min predominantly aerobic training, 30 min of strength training, and 5 min cooldown). The remaining 20 women (51.5 ± 9.5 years) were advised to remain active during treatments, but without specific supervision. In the PE group, a slight reduction in the LVEF was observed after chemotherapy (63.73 ± 3.34% vs. 61.00 ± 6.54%, p = 0.131). In contrast, the control group showed a statistically significant reduction in the LVEF (64.93 ± 4.00% vs. 60.57 ± 4.86%, p = 0.008). Although the results suggest a potential protective effect of regular physical exercise during BC treatment, the study was inconclusive regarding its role in preventing cardiac dysfunction. Further research with a larger sample size and longer follow-up is warranted.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (2025) studied Breast cancer undergoing chemotherapy (n=38). Supervised physical exercise program vs. Advised to remain active without specific supervision was evaluated on Left ventricular ejection fraction (LVEF) after chemotherapy. Supervised physical exercise during breast cancer chemotherapy resulted in a non-significant LVEF reduction (to 61.0%, p=0.131), whereas controls had a significant reduction (to 60.6%, p=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: